Boehringer Ingelheim sales and marketing update

Boehringer's Boehringer Ingelheim Pharmaceuticals Inc. unit (Ridgefield, Conn.) launched Atrovent HFA ipratropium inhaled bronchodilator in the U.S. for maintenance treatment of bronchospasm associat...